Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Abstract With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly...
Guardado en:
Autores principales: | Ting Cai, Huina Liu, Shun Zhang, Jing Hu, Lingxiao Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8efa55ab0ae4d62b5de991db51d14d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
por: Menglu Zhu, et al.
Publicado: (2021) -
Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery
por: Wenyan Hao, et al.
Publicado: (2021) -
Correction to: Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer
por: Haixian Zhang, et al.
Publicado: (2021) -
Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment
por: Xiaojing Xu, et al.
Publicado: (2021) -
Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles
por: Qingle Ma, et al.
Publicado: (2021)